A New Proposal for Children's "Digital Stress Eye Fatigue": Rohto Pharmaceutical Launches "Rohto Eye Vision," Featuring Japan's Only*1 BTA Formulation Focused on Pediatric Eye Inflammation
Rohto Pharmaceutical is set to launch "Rohto Eye Vision" on March 26, 2026, an eye drop designed to combat "digital stress-induced eye fatigue" in children. The product features a proprietary BTA formulation that addresses eye surface inflammation, a common side effect of prolonged digital device use in children.
📋 Article Processing Timeline
- 📰 Published: March 28, 2026 at 00:24
- 🔍 Collected: March 28, 2026 at 21:59 (21h 35m after Published)
- 🤖 AI Analyzed: April 15, 2026 at 02:17 (412h 17m after Collected)
Rohto Pharmaceutical Co., Ltd. (Headquarters: Osaka, President: Hidetoshi Segi) will release "Rohto Eye Vision," eye drops for children that focus on "eye fatigue caused by digital stress*2" resulting from the use of digital devices such as smartphones and tablets, starting Thursday, March 26, 2026.
Through our unique "BTA formulation (Berberine chloride hydrate, Taurine, Sodium azulene sulfonate hydrate)," we provide multi-faceted care for the "inflammation of the eye surface" that easily occurs when using digital devices. This is a proposal aimed at supporting the "recovery of children's ability to see."
*1 Based on research as of March 2025 using the PMDA website's Over-the-Counter and Instructional Drug Information Search and the JAPIC Over-the-Counter Drug Compendium 2025.
*2 Refers to excessive use of digital devices, etc.
■ Background of Product Launch
The digital environment surrounding children today is expanding rapidly. According to a survey by the Children and Families Agency, internet usage is widespread among children, including those in lower age groups, with approximately 90% of elementary school students (ages 6-9) using it.*3
Furthermore, the smartphone usage rate among elementary school students aged 10 and older has increased from 49.8% in fiscal year 2019 to 66.7% in fiscal year 2024. The usage rate of computers and tablets distributed or designated by schools (GIGA terminals) has also grown significantly, from 50% in a fiscal year 2021 survey to 75.9%.*3
Digital device usage tends to increase with age; for elementary school students aged 10 and older, the average daily usage time has reached approximately 3 hours and 44 minutes, indicating a reality where digital exposure increases further as children progress through school-age years.*3 Additionally, regarding smartphones, the ratio of "dedicated" to "shared" devices flips at age 10, with the ratio of child-dedicated devices exceeding 65%, changing not only the usage time but also the usage environment itself.*3
Utilizing digital devices is no longer a temporary trend; it has become a part of the foundation for learning and daily life. On the other hand, the burden on the eyes and the impact on visual function associated with long-term use have emerged as health issues that society as a whole must face. While interest in the progression of myopia is rising, the current reality is that concrete measures to protect children's eye health are not sufficient.
In particular, when using digital devices, inflammation of the eye surface is prone to occur due to a decrease in blinking, which is a cause of eye fatigue. However, conventional children's eye drops have focused primarily on responding to symptoms such as "itching" or "redness," and products focused on eye fatigue caused by digital stress have been limited.
Our company has continuously addressed issues related to visual function through research on children's eye health, educational activities, initiatives in the device field, and collaborative projects with local governments. In the modern era, where coexistence with digital devices is a prerequisite, protecting children's ability to see is an important social theme. Based on this background, we have developed this product as a new care option focused on digital stress.
*3: (Source) Children and Families Agency, FY2024 Survey on the Actual Conditions of Internet Usage Environment for Youth
■ Product Features
① Japan's Only*1 BTA Formulation Focused on "Inflammation Symptoms" That Cause Digital Fatigue
A unique Rohto formulation combining Berberine chloride hydrate (B), Taurine (T), and Sodium azulene sulfonate hydrate (A).
We care for your child's eyes from two directions regarding the "inflammation" that causes digital fatigue:
Inhibition: Suppresses the production of inflammatory substances
Sedation: Calms inflammation that has already occurred
② Formulated with Focus Adjustment Function Improvement and Corneal Protection Ingredients
Neostigmine methyl sulfate approaches fatigue in the focus-adjusting muscles.
Contains Sodium chondroitin sulfate (a corneal protection ingredient).
③ Can be used from 1 year old / No benzalkonium chloride or parabens as preservatives
Can be used by young children aged 1 year and older, supporting self-care for those suffering from symptoms regardless of age.
■ Brand Site
https://jp.rohto.com/kidseye/rohto-eyevision/
■ Product Summary
[Image Placeholder]
● "Eye Vision" is a registered trademark of Rohto Pharmaceutical Co., Ltd.
● "BTA" is a registered trademark of Rohto Pharmaceutical Co., Ltd.
Through our unique "BTA formulation (Berberine chloride hydrate, Taurine, Sodium azulene sulfonate hydrate)," we provide multi-faceted care for the "inflammation of the eye surface" that easily occurs when using digital devices. This is a proposal aimed at supporting the "recovery of children's ability to see."
*1 Based on research as of March 2025 using the PMDA website's Over-the-Counter and Instructional Drug Information Search and the JAPIC Over-the-Counter Drug Compendium 2025.
*2 Refers to excessive use of digital devices, etc.
■ Background of Product Launch
The digital environment surrounding children today is expanding rapidly. According to a survey by the Children and Families Agency, internet usage is widespread among children, including those in lower age groups, with approximately 90% of elementary school students (ages 6-9) using it.*3
Furthermore, the smartphone usage rate among elementary school students aged 10 and older has increased from 49.8% in fiscal year 2019 to 66.7% in fiscal year 2024. The usage rate of computers and tablets distributed or designated by schools (GIGA terminals) has also grown significantly, from 50% in a fiscal year 2021 survey to 75.9%.*3
Digital device usage tends to increase with age; for elementary school students aged 10 and older, the average daily usage time has reached approximately 3 hours and 44 minutes, indicating a reality where digital exposure increases further as children progress through school-age years.*3 Additionally, regarding smartphones, the ratio of "dedicated" to "shared" devices flips at age 10, with the ratio of child-dedicated devices exceeding 65%, changing not only the usage time but also the usage environment itself.*3
Utilizing digital devices is no longer a temporary trend; it has become a part of the foundation for learning and daily life. On the other hand, the burden on the eyes and the impact on visual function associated with long-term use have emerged as health issues that society as a whole must face. While interest in the progression of myopia is rising, the current reality is that concrete measures to protect children's eye health are not sufficient.
In particular, when using digital devices, inflammation of the eye surface is prone to occur due to a decrease in blinking, which is a cause of eye fatigue. However, conventional children's eye drops have focused primarily on responding to symptoms such as "itching" or "redness," and products focused on eye fatigue caused by digital stress have been limited.
Our company has continuously addressed issues related to visual function through research on children's eye health, educational activities, initiatives in the device field, and collaborative projects with local governments. In the modern era, where coexistence with digital devices is a prerequisite, protecting children's ability to see is an important social theme. Based on this background, we have developed this product as a new care option focused on digital stress.
*3: (Source) Children and Families Agency, FY2024 Survey on the Actual Conditions of Internet Usage Environment for Youth
■ Product Features
① Japan's Only*1 BTA Formulation Focused on "Inflammation Symptoms" That Cause Digital Fatigue
A unique Rohto formulation combining Berberine chloride hydrate (B), Taurine (T), and Sodium azulene sulfonate hydrate (A).
We care for your child's eyes from two directions regarding the "inflammation" that causes digital fatigue:
Inhibition: Suppresses the production of inflammatory substances
Sedation: Calms inflammation that has already occurred
② Formulated with Focus Adjustment Function Improvement and Corneal Protection Ingredients
Neostigmine methyl sulfate approaches fatigue in the focus-adjusting muscles.
Contains Sodium chondroitin sulfate (a corneal protection ingredient).
③ Can be used from 1 year old / No benzalkonium chloride or parabens as preservatives
Can be used by young children aged 1 year and older, supporting self-care for those suffering from symptoms regardless of age.
■ Brand Site
https://jp.rohto.com/kidseye/rohto-eyevision/
■ Product Summary
[Image Placeholder]
● "Eye Vision" is a registered trademark of Rohto Pharmaceutical Co., Ltd.
● "BTA" is a registered trademark of Rohto Pharmaceutical Co., Ltd.